Introducing: The Future of Cell Engineering
At EditCo Bio, we're dedicated to making genome engineering easier, faster, and more reliable.
Building Functional, Reliable CRISPR-edited Primary Cells
Streamline your research with edited-to-order primary cells, including our new Knockout CD4+ & CD8+ T-cells.
Now, Express Edited Cells with Your Cell Lines
Reliable, fast, and flexible: EditCo's new Express Cell Pool service for your unique cell lines.
Simplified CRISPR: From Design to Delivery
We make it easy for researchers to choose genes and yield and order in just a few clicks. Pick your genes and get started today.
We deliver optimized, multi-guide CRISPR kits and made-to-order edited cells.
0+
0%
0+
0+
Explore CRISPR kits and engineered cell services.
Immortalized Cells
Knockout Immortalized Cell Lines
CRISPR knockout cells streamline gene editing, providing ready-to-use cell lines and eliminating months of optimization.
Knock-in Immortalized Cell Lines
Receive precision edits for disease modeling and protein studies, bypassing the complexity of DIY CRISPR.
Express Knockout Cell Lines
Increase your speed to critical data with express-edited immortalized cells, offering an impressive 80 percent knockout efficiency and delivery in under 2 weeks.
Knockout Cell Libraries
Get faster results, scale easily, and lead with certainty as you screen results and advance your research project.
iPS Cells
Knockout iPS Cell Lines
EditCo's CRISPR Knockout iPS Cells ensure industry-leading editing efficiency in iPS cells, without compromising cell quality. Get reliable gene knockout for critical gene function and disease linkage studies with the assurance of cell integrity.
Knock-in iPS Cell Lines
EditCo's advanced CRISPR knock-in edits in iPS cells unlock breakthrough potential in neuroscience and regenerative medicine. Our efficient automated process for high-quality reproducible iPS cell edits paves the way for your groundbreaking research and therapeutic development.
Primary Cells
Knockout CD8+ T-cells
Advance your immunology research with edited-to-order primary CD8+ T-cells. Unparalleled editing accuracy and efficiency enable you to bypass the time and resources spent on optimization. EditCo's consistent and functional T-cells ensure post-editing experimental reliability and robust downstream results.
Knockout CD4+ T-cells
Focus on the main experiments with edited CD4+ T-cells. Fast results and guaranteed smart multi-guide design ensure high dependability and cell viability. EditCo’s accurate and reliable T-cells deliver functional data while reducing the risk of false negatives in your critical assays.
CRISPR Reagents
Arrayed CRISPR sgRNA Libraries
Achieve reliably high knockout efficiencies across your entire CRISPR screen for any human or mouse protein-coding gene. Identifying and validating your targets has never been faster and more reliable, with unparalleled quick delivery starting at 7 days and guaranteed editing efficiency.
Gene Knockout Kits
Knockout any human or mouse protein-coding gene with our unique multi-guide RNA strategy. Three spatially coordinated modified SpCas9 sgRNAs induce fragment deletions, obtaining knockout rates greater than 80 percent, and it ships in as few as 5 days—the most reliable knockout strategy, guaranteed.
Leverage EditCo’s gene-editing expertise to support your research.
Consistent
Comprehensive
Collaborative
Testimonials
EditCo has proven to be an invaluable partner in advancing our—and our client's—research. We highly recommend their services to any organization seeking a reliable, efficient, and skilled collaborator in the field of gene editing.
ATCC and EditCo’s strategic partnership brings together the gold standard in authenticated cell lines with EditCo’s leading CRISPR gene-editing tools and services. This powerful alliance allows researchers to harness the highest-quality edited cells, accelerating their research with unparalleled speed, precision, reproducibility, and quality.
We chose EditCo's Arrayed CRISPR Library for our screening project after testing different reagents and finding that the multi-guide RNA design results in superior editing and knockout efficiency. This superior efficiency improves the sensitivity of our screen by enhancing our ability to detect phenotypes—in particular, weak phenotypes—resulting from knockouts.
At EditCo, our journey began within the pioneering gene-editing landscape of Synthego. We honed our expertise for 5 years, contributing to the gene-editing revolution, and decided to expand into our own company, focusing on quality cell engineering solutions. With our experience as CRISPR leaders, our innovative editing platform, and the highest-quality products, we're here to propel our customers' scientific breakthroughs.
Partners in Innovation
When you partner with EditCo, you harness the transformative power of genome engineering for life science R&D and drive forward human health advancements. Through our Discovery Partners Ecosystem, we offer a unified platform from engineered cells to phenotypic data, streamlining the research process to accelerate drug discovery.
AI, CRISPR, and Automation in Oncology Drug Discovery
Learn how the team at Evariste has been using AI to accelerate drug discovery, along with the help of two powerful automated platforms: CRISPR editing through EditCo's Express Cell Pools and assay development through Arctoris' Ulysses.